{"id":645810,"date":"2023-04-06T14:44:01","date_gmt":"2023-04-06T14:44:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=645810"},"modified":"2023-04-06T14:44:01","modified_gmt":"2023-04-06T14:44:01","slug":"sturgeweber-syndrome-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-qlaris-bio-inc-jazz-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/sturgeweber-syndrome-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-qlaris-bio-inc-jazz-pharmaceuticals_645810.html","title":{"rendered":"Sturge-Weber Syndrome Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies – Qlaris Bio Inc, Jazz Pharmaceuticals"},"content":{"rendered":"
\n
\"Sturge-Weber<\/a><\/div>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Sturge-weber Syndrome (SWS) Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Sturge-weber Syndrome (SWS), historical and forecasted epidemiology as well as the Sturge-weber Syndrome (SWS) market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.<\/div>\n

DelveInsight’s “Sturge-weber Syndrome (SWS) Market Insights, Epidemiology, and Market Forecast-2032<\/a><\/strong>” report delivers an in-depth understanding of the Sturge-weber Syndrome (SWS), historical and forecasted epidemiology as well as the Sturge-weber Syndrome (SWS) market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.<\/p>\n

 Sturge-Weber Syndrome Overview<\/strong><\/p>\n

 Sturge–Weber syndrome, sometimes referred to as encephalotrigeminal angiomatosis, is a rare congenital neurological and skin disorder. It is one of the phakomatoses and is often associated with port-wine stains of the face, glaucoma, seizures, intellectual disability, and ipsilateral leptomeningeal angioma (cerebral malformations and tumors). Sturge–Weber syndrome can be classified into three different types, type 1, type 2, and type 3.<\/p>\n

Sturge–Weber is an embryonal developmental anomaly resulting from errors in mesodermal and ectodermal development. Unlike other neurocutaneous disorders (phakomatoses), Sturge–Weber occurs sporadically (i.e., does not have a hereditary cause). It is caused by a mosaic, somatic activating mutation occurring in the GNAQ gene. Imaging findings may include tram track calcifications on pial angiomatosis and hemicerebral atrophy.<\/p>\n

\"\"<\/p>\n

 The Report Covers the Sturge-Weber Syndrome Epidemiology Segmented by –<\/strong><\/p>\n